Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Bernstein bets on Indian healthcare, sees these three stocks as key beneficiaries
According to Bernstein, valuations across the Indian biopharma sector have re-rated significantly, with the Nifty Pharma index trading slightly above its 10-year average multiple of 30.5 times its one-year forward earnings. However, it noted that its preferred stocks continue to trade below their long-term average valuations.
NLC India shares in focus as government's Offer For Sale opens for non-retail investors
Among the public shareholders, mutual funds of India had a 9.49% stake in NLC India, led mainly by Nippon Life India AMC (5.65%) and Kotak Mahindra MF (2.6%). The stock is up over 30% so far in 2026.
Sebi reviews broker net-worth norms, IPO price discovery framework
Market regulator is examining broker capital requirements, IPO auction mechanisms, mutual fund liquidity rules and corporate bond market reforms to improve efficiency
Tata Mutual Fund Curbs Large Inflows Into Gold ETFs Amid Record Surge in Demand
Tata Mutual Fund offers investors two routes to gain exposure to gold ETFs.
Global Capital Is Chasing AI Giants, But India Remains a Stock Picker's Market, Says Hiren Ved
The veteran fund manager noted that while the Nifty has largely moved sideways over the past two years, several stocks have generated substantial returns during the same period.
Sensex slides 530 pts; Nifty trades below 23,200 level; VIX jumps 7.25%
The Nifty traded below the 23,200 level. Barring the pharma index, all other shares declined on the NSE.
Ipca Laboratories Ltd soars 0.79%, rises for fifth straight session
Ipca Laboratories Ltd is quoting at Rs 1654.8, up 0.79% on the day as on 12:44 IST on the NSE. The stock is up 20.85% in last one year as compared to a 7.43% spurt in NIFTY and a 11.54% spurt in the Nifty Pharma.
Quantum Advisors' Nilesh Shetty sees value in private banks and IT; trims exposure to metals
Nilesh Shetty, Portfolio Manager at Quantum Advisors, believes India could benefit if the global AI trade loses momentum, though he does not expect foreign inflows to pick up meaningfully amid concerns over the rupee and geopolitical tensions. The fund remains positive on private sector banks, insurance companies and large-cap pharma stocks, while selectively adding IT services and logistics names. At the same time, it has been trimming metal and commodity exposure after a strong three-year rally, with Shetty seeing better opportunities in IT for patient investors. Disclaimer: The views and investment tips expressed by investment experts on CNBCTV18.com are their own and not that of the website or its management. CNBCTV18.com advises users to check with certified experts before taking any investment decisions.
Sun Pharma, Alkem Labs, other pharma stocks gain despite stock market crash; Nifty Pharma rises for fourth day in a row - Mint
Sun Pharma, Alkem Labs, other pharma stocks gain despite stock market crash; Nifty Pharma rises for fourth day in a rowMint
Here is the one sector bucking the trend in a weak market; Check out top gainers
Five among the top 10 gainers on the Nifty 500 index are Pharma stocks. They include Pfizer (Up 4.6%), Anthem Biosciences (Up 2.5%), Syngene (Up 2%), Aster DM Healthcare (Up 2%) and Wockhardt (Up 2%).
Two Adani Group stocks in focus as GQG sells stake in Rs 5,750 crore deal; SBI MF lone buyer
Adani Enterprises and Adani Energy Solutions will be in focus after GQG Partners sold stakes worth about Rs 5,750 crore via block deals, with SBI Mutual Fund buying the shares. The move is seen as portfolio rebalancing following a strong recovery in Adani Group stocks over the past year.
Smart money move: Why Groww MF's equity chief is betting on multicap strategies
Anupam Tiwari of Groww Mutual Fund warns of a potential oil shock. He believes a multicap strategy combined with bottom-up investing is suitable for current market conditions. Valuations in mid and small caps have improved, making active stock picking more viable. Tiwari highlights opportunities in financials, industrials, autos, and specialty chemicals.